²¨É«µ¥Ë«

Skip to Content on Nemours.org
You're location is
All Regions
²¨É«µ¥Ë«

Nationally Recognized Pediatric Care

Our hospitals are ranked by U.S. News & World Report as among the best in the nation in multi-specialties.

Find Out Why!
Closeup of a person holding a phone using the Nemours app.

We Make Health Care Easy With the Nemours App

Access communications, appointment and symptom tracking and more.

Online Bill Pay

Paying a bill online is easy and secure.

Learn More

Send a Free E-Card

Brighten the day of your loved one staying at one of our hospitals.Ìý

Give It a Try
Young child posing with arms out like he is flying.

KidsHealth Library

Healthy living forÌýparents, kids andÌýteens.

Meet Our Team

Learn more about our physician researchers, clinicians and scientists.

Find a Researcher
# #

    Ricki S. Carroll, MD

    Genetics
    (800) 416-4441

    Primary Office

    ²¨É«µ¥Ë« Hospital, Delaware ²¨É«µ¥Ë« Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803
    Appointment: (800) 416-4441

    Other Offices

    Get to Know Me

    Dr. Ricki Carroll is a complex care and palliative care physician on the skeletal dysplasia and palliative care teams at Nemours Children’s Hospital, Delaware. Dr. Carroll works to provide a medical home and manage care for children with a wide array of skeletal dysplasias. Her background in palliative medicine allows her to focus on pain and symptom management needs for these children, teens and young adults. Dr. Carroll also leads the skeletal dysplasia consultative service, providing care for infants and children with skeletal dysplasias who are in the hospital. Additionally, drawing upon her Master’s in Bioethics, she is currently serving as co-Chair of the Nemours Ethics and Patients’ Rights Committee.

    What I'm Passionate About

    It’s an honor and a privilege to care for families, children and teens with skeletal dysplasias and medically complex conditions.Ìý I aim to treat each child or teen as a whole, and not just treat the individual condition, as I feel spiritual and emotional needs are just as important as medical and physical ones. I try to intently listen to each child or teen and family when they are under my care, in hopes of understanding their story and their experience and, therefore, focusing goals of care to their individual needs. My medical interests include:Ìý Clinical management of infants with skeletal dysplasias, including OI, thanatophoric dysplasia, and collagen-II-opathies Emerging medical treatments for skeletal dysplasias The elucidation of the natural history of OI and skeletal dysplasias The role of biomarkers in all skeletal dysplasias Management of chronic pain in adolescents and young adults with skeletal dysplasias Complex medical conditions Palliative care

    How I Try to Make A Difference

    I try to make a difference by focusing on each child or teen as if they are my one and only patient. I aim to provide a comforting environment for kids while they are in our care and always consider how to better manage symptoms and control any pain. I earned a master's degree in bioethics, and often call upon what I learned to help inform how I view the way the hospital and our teams deliver excellent care to children and teens.

    Education & Training

    Fellowship

    • Palliative Care - Alfred I. duPont Hospital for Children, 2019

    Residency

    • General Pediatrics - The Children's Hospital of Philadelphia, 2015

    Medical/Dental School

    • M.D. - University of Pennsylvania School of Medicine, 2012

    Board Certifications

    • American Board of Pediatrics/Hospice & Palliative Medicine
    • American Board of Pediatrics/General Pediatrics

    Awards & Recognition

    • 2021 Rising Star Award, Nemours Physician Excellence Awards

    • Skeletal Dysplasia

    Research Activities

    My research mainly concerns children with skeletal dysplasias. I serve as a co-Investigator for multiple clinical trials, including those involving patients with achondroplasia, rhizomelic chondrodysplasia punctate (RCDP), and Sanfilippo syndrome (MPS III).Ìý I am involved in projects related to biomarkers in children with skeletal dysplasias, as well.ÌýÌý

    Ìý

    I also work on projects focused on quality improvement research within the field of palliative care, as well as ethics resident education.

    Medical Interests

    • Palliative care
    • Complex medical conditions
    • Skeletal dysplasia
    • Osteogenesis imperfecta

    • Author Correction: Specific heterozygous variants in MGP lead to endoplasmic reticulum stress and cause spondyloepiphyseal dysplasia; Nature Communications; (2024).

    • Vosoritide Therapy in Children with Achondroplasia: Early Experience and Practical Considerations for Clinical Practice; Advances in Therapy; (2024).

    • Trends in Serum Cytokine Expression in Pediatric Skeletal Dysplasia; JBMR Plus; (2023).

    • Specific heterozygous variants in MGP lead to endoplasmic reticulum stress and cause spondyloepiphyseal dysplasia; Nature Communications; (2023).

    • Identification of potential non-invasive biomarkers in diastrophic dysplasia.; Bone; (2023).

    • An Informed Approach to Vaccine Hesitancy and Uptake in Children.; Delaware journal of public health; (2022).

    • Collagen X Marker Levels are Decreased in Individuals with Achondroplasia; Calcified Tissue International; (2022).

    • Microcephalic osteodysplastic primordial dwarfism type II is associated with global vascular disease.; Orphanet journal of rare diseases; (2021).

    • Comprehensive pain management strategy for infants with moderate to severe osteogenesis imperfecta in the perinatal period; Paediatric and Neonatal Pain; (2021).

    • Should We Stop Calling Thanatophoric Dysplasia a Lethal Condition? A Case Report of a Long-Term Survivor.; Palliative medicine reports; (2020).

    • End-of-life medical decision-making for children in custody: A collaborative, multi-stakeholder practical approach.; Child abuse & neglect; (2020).

    • Sudden Unexpected Infant Death: A Compassionate Forensic Approach to Care; Clinical Pediatric Emergency Medicine; (2012).

    • Motivations of patients with pulmonary arterial hypertension to participate in randomized clinical trials.; Clinical trials (London, England); (2012).

    • English